Kidney involvement and associated risk factors in children with Duchenne muscular dystrophy

Muhammet Gültekin Kutluk1, Çağla Serpil Doğan2

  • 1Department of Pediatrics, Division of Pediatric Neurology, Antalya Training and Research Hospital, 07059, Antalya, Turkey.

Insights

Pediatric Duchenne muscular dystrophy (DMD) patients show early signs of kidney issues, including hypertension and abnormal urine composition. Elevated cystatin C levels correlate with muscle damage markers, suggesting a risk of chronic kidney impairment in these children.

Area of Science:

  • Pediatric Nephrology
  • Neuromuscular Disorders
  • Clinical Biochemistry

Background:

  • Kidney dysfunction is a known complication in adult Duchenne muscular dystrophy (DMD) patients.
  • Kidney function in pediatric DMD patients has been understudied.
  • This study investigates kidney function in children and adolescents with DMD.

Purpose of the Study:

  • To assess kidney function in pediatric patients with Duchenne muscular dystrophy.
  • To identify potential markers and risk factors for kidney impairment in this population.
  • To establish baseline data for future longitudinal studies.

Main Methods:

  • Retrospective review of medical records for 44 pediatric DMD patients (aged 5-18 years) with over 12 months of follow-up.
  • Evaluation of blood pressure via 24-hour ambulatory monitoring.
  • Analysis of 24-hour urine samples for proteinuria, calciuria, and phosphaturia.
  • Measurement of serum cystatin C (CysC), creatinine (Cr), creatine kinase (CK), and parathormone (PTH) levels.

Main Results:

  • Hypertension detected in 32.1% of patients, with 87.5% on steroid therapy.
  • Abnormalities in urine composition included mild proteinuria (8.3%), hypercalciuria (13.9%), hypocalciuria (19.7%), and hyperphosphaturia (16.7%).
  • Elevated cystatin C (CysC) showed positive correlations with creatinine (Cr), creatine kinase (CK), and parathormone (PTH), with higher CysC levels linked to increased CK, PTH, and Cr.

Conclusions:

  • Pediatric DMD patients exhibit various kidney function abnormalities, including hypertension and altered urine composition.
  • Elevated cystatin C may serve as an indicator of kidney stress in pediatric DMD.
  • Long-term exposure to muscle breakdown products could increase the risk of chronic kidney impairment in pediatric DMD patients.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
463
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
454
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
263
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.6K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
239
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.2K